|Day Low/High||8.60 / 9.25|
|52 Wk Low/High||4.63 / 9.91|
Sangamo Therapeutics, Epizyme and Revance were among the biotech stock movers in premarket trading on June 21.
The most recent short interest data has been released for the 05/31/2017 settlement date, which shows a 1,311,426 share increase in total short interest for Sangamo Therapeutics Inc , to 9,274,371, an increase of 16.47% since 05/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Companies also Announce Phase 1/2 Clinical Trial Evaluating SB-525 in Adults with Severe Hemophilia A is Now Open for Enrollment
Here's what I'm trading today amid the 'flat with a positive tone' action.
Collaboration combines Pfizer's heritage in Rare Disease, capabilities in gene therapy, and expertise in hemophilia with Sangamo's deep knowledge in genomic therapies
Aratana Therapeutics, Trevena and Sangamo Therapeutics were among the biotech stock movers in premarket trading on Thursday.
Rare Pediatric Disease Designation for SB-913 In Vivo Genome Editing Treatment for MPS II
Vertex Pharmaceuticals, Sangamo Therapeutics and Depomed were among the biotech stock movers in premarket trading on Wednesday.
Engineered Zinc Finger Protein Transcription Factors Lowered Tau Levels by More Than 90% in Human Neurons In Vitro and Reduced Neuritic Dystrophy in Amyloid Mouse Model of Alzheimer's Disease
Investors eyeing a purchase of Sangamo Therapeutics Inc stock, but tentative about paying the going market price of $4.18/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2018 put at the $3 strike, which has a bid at the time of this writing of 50 cents.
Kathy Yi Appointed to Succeed H. Ward Wolff as CFO Upon His Retirement in March
BioCryst Pharmaceuticals, Sangamo Therapeutics and Cempra were among the biotech stock movers in premarket trading on Monday.